Alex More has been permanently suspended from twitter for persistent hounding of authorities to get #Evusheld.
He broke twitter rules out sheer desperation and paid the price.
@NHSEngland@HPFT_NHS Paxlovid for Covid interacts with anti-rejection meds and can cause toxicity in immunocompromised people. Keep the drugs that are still showing some efficacy: Sotrovimab and Remdesivir.
11:10
@UKHSA Stop NICE from ditching #Remdesivir and #Sotrovimab the last effective covid antivirals for those immunocompromised who can't take #Paxlovid.
The #Forgotten500K do not respond to vaccines.
https://t.co/XwDGDkwm9v
11:10
@UKHSA NICE plans to remove #Remdesivir#Sotrovimab and #Molnupiravir for immunocompromised who can't take #Paxlovid.
"While there is clinical evidence that they are effective at treating COVID-19 they were not found to be cost effective."
https://t.co/VpsSbCflCK
11:10
@DHSCgovuk UKHSA and NICE. You waited until #Evusheld became ineffective against new variants. You deprived immunocompromised people of nearly 6 months freedom. Don't make the same mistake with AZ Supernova. https://t.co/EP0K4j2eyT
11:10
@NHSEngland NICE plans to remove #Remdesivir#Sotrovimab and #Molnupiravir for immunocompromised who can't take #Paxlovid.
"While there is clinical evidence that they are effective at treating COVID-19 they were not found to be cost effective."
https://t.co/VpsSbCflCK
11:10
@NHSEngland UKHSA and NICE. You waited until #Evusheld became ineffective against new variants. You deprived immunocompromised people of nearly 6 months freedom. Don't make the same mistake with AZ Supernova. https://t.co/EP0K4j2eyT
11:10
@UKHSA NICE don't take away #Sotrovimab and #Remdesivir for Covid. Paxlovid interacts with many transplant patients anti-rejection medicine. This leaves them at risk of toxcity.
11:10
@SteveBarclay NICE don't take away #Sotrovimab and #Remdesivir for Covid. Paxlovid interacts with many transplant patients anti-rejection medicine. This leaves them at risk of toxcity.
11:10
@UKHSA NICE plans to remove #Remdesivir#Sotrovimab and #Molnupiravir for immunocompromised who can't take #Paxlovid.
"While there is clinical evidence that they are effective at treating COVID-19 they were not found to be cost effective."
https://t.co/VpsSbCflCK
11:10
@NHSEngland@KingsCollegeNHS Paxlovid for Covid interacts with anti-rejection meds and can cause toxicity in immunocompromised people. Keep the drugs that are still showing some efficacy: Sotrovimab and Remdesivir.
11:10
@SteveBarclay @BMA_JuniorDocs NICE plans to remove #Remdesivir#Sotrovimab and #Molnupiravir for immunocompromised who can't take #Paxlovid.
"While there is clinical evidence that they are effective at treating COVID-19 they were not found to be cost effective."
https://t.co/VpsSbCflCK
16:48
@UKHSA@DefraGovUK NICE plans to remove #Remdesivir#Sotrovimab and #Molnupiravir for immunocompromised who can't take #Paxlovid.
"While there is clinical evidence that they are effective at treating COVID-19 they were not found to be cost effective."
https://t.co/VpsSbCflCK
16:48
@DHSCgovuk NICE plans to remove #Remdesivir#Sotrovimab and #Molnupiravir for immunocompromised who can't take #Paxlovid.
"While there is clinical evidence that they are effective at treating COVID-19 they were not found to be cost effective."
https://t.co/VpsSbCflCK
16:48
@UKHSA UKHSA and NICE. You waited until #Evusheld became ineffective against new variants. You deprived immunocompromised people of nearly 6 months freedom. Don't make the same mistake with AZ Supernova. https://t.co/EP0K4j2eyT
16:48
@UKHSA Stop NICE from ditching #Remdesivir and #Sotrovimab the last effective covid antivirals for those immunocompromised who can't take #Paxlovid.
The #Forgotten500K do not respond to vaccines.
https://t.co/XwDGDkwm9v
16:48
@NHSEngland Stop NICE from ditching #Remdesivir and #Sotrovimab the last effective covid antivirals for those immunocompromised who can't take #Paxlovid.
The #Forgotten500K do not respond to vaccines.
https://t.co/XwDGDkwm9v
16:48